Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis

摘要

Objectives:Early osteoporotic fractures have a great impact on disease progression, the first fracture being a major risk factor for further fractures. Strontium ranelate efficacy against vertebral fractures is presently assessed in a subset of women aged 50–65 years.